ANN ARBOR, Mich., – Oct 8, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, is very happy to announce today that the Company has officially initiated commercial production scale up of its recombinant spider silk production at its Vietnamese subsidiary, Prodigy Textiles. During a trip this week Jon Rice, the Company’s chief operating officer, successfully delivered the Company’s specialized silkworm eggs to the production team, at Prodigy Textiles’ recently renovated factory. This moment marks a pivotal milestone in the commercialization and production of eco-friendly and cost effective recombinant spider silk.
“The significance of today’s announcement can’t be overstated. By clearing this critical production hurdle, we are now aggressively ramping up to produce and fill demand for our recombinant spider silk materials,” said Rice. “Having demonstrated our materials’ performance capabilities and secured necessary approvals, we are now focused on the exciting next phase of our business model; delivering our high performance silk yarns to the market and formalizing strategic partnerships. Our dream of a sustainable and cost effective method to produce recombinant spider silk is now in operation.”
With capacity scale up now officially underway in Vietnam, the Company is focused on the production of its recombinant spider silk threads and yarns for delivery to collaborative partners and target market segments.
The Company has been working with senior officials in Vietnam for several years to secure the necessary permits and approvals needed to bring its revolutionary spider silk technology to production. The delivery of these progenitor silkworms into the Company’s Vietnamese facility marks the success of that process and the beginning of a new era in performance textiles.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC